Thursday, June 03, 2021 5:45:53 PM
Our Strongest cards for Ifenprodil and AGN. IMO.
I'm INVESTED in the bet AGN CEO C.M. is able to pull off a success. Defined as a Phase 3 directed at patients existing with low O2 / ALI / and maybe Pulmonary Fibrosis all from COVID. Now THAT would be a Marketable Hand...GLTA...
BTW, other popular companies are applying for EUA with less than 200 patient CTs. None with the sound science and Safety of Ifenprodil. IMO.
The latrine lawyering skills of some are impressive. Most LLs post with an IMO... IMO...
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM